Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resting-state electroretinography reveals pathological retinal oscillations in retinitis pigmentosa mice and patients.

Nature communications·2026
Same author

Clinical and genetic basis of congenital gonadotropin deficiency.

Human reproduction open·2026
Same author

Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane.

NPJ breast cancer·2026
Same author

Pleiotropic genes linking congenital hypogonadotropic hypogonadism and cleft lip/palate: evidence from a genomic CHH cohort study.

European journal of human genetics : EJHG·2026
Same author

CATT haplotype of the FKBP5 gene and dissociative phenomenology.

Scientific reports·2025
Same author

Gene editing for Spinocerebellar ataxia type 3 taking advantage of the human ATXN3L paralog as replacement gene.

Gene therapy·2025

Related Experiment Video

Updated: Dec 15, 2025

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.7K

Maximizing lentiviral vector gene transfer in the CNS.

Morgane Humbel1,2, Mergim Ramosaj1,2, Virginie Zimmer1,2

  • 1Lausanne University Hospital (CHUV) and University of Lausanne, Department of Clinical Neurosciences (DNC), Laboratory of Neurotherapies and NeuroModulation, Lausanne, Switzerland.

Gene Therapy
|July 8, 2020
PubMed
Summary

Researchers developed advanced lentiviral vectors (LVs) for improved gene transfer in the central nervous system (CNS). This novel strategy enhances gene therapy for neurological disorders by enabling targeted delivery and broad distribution.

More Related Videos

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI
06:49

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI

Published on: May 24, 2022

2.9K
Direct Injection of a Lentiviral Vector Highlights Multiple Motor Pathways in the Rat Spinal Cord
07:57

Direct Injection of a Lentiviral Vector Highlights Multiple Motor Pathways in the Rat Spinal Cord

Published on: March 15, 2019

9.0K

Related Experiment Videos

Last Updated: Dec 15, 2025

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System
08:46

Production of Lentiviral Vectors for Transducing Cells from the Central Nervous System

Published on: May 24, 2012

36.7K
Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI
06:49

Lentiviral Mediated Delivery of shRNAs to hESCs and NPCs Using Low-cost Cationic Polymer Polyethylenimine PEI

Published on: May 24, 2022

2.9K
Direct Injection of a Lentiviral Vector Highlights Multiple Motor Pathways in the Rat Spinal Cord
07:57

Direct Injection of a Lentiviral Vector Highlights Multiple Motor Pathways in the Rat Spinal Cord

Published on: March 15, 2019

9.0K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene transfer is crucial for studying and treating genetic diseases.
  • The central nervous system (CNS) presents significant challenges for gene therapy due to its complexity and restricted access.
  • Targeting specific cell subpopulations within the CNS is essential for effective neurological treatments.

Purpose of the Study:

  • To enhance gene transfer efficacy and capacity within the CNS.
  • To develop lentiviral vectors (LVs) for selective targeting of cell subpopulations.
  • To explore strategies for broad distribution and targeting of affected brain circuits.

Main Methods:

  • Development of a second-generation LV with specific tropism for astrocytes.
  • Utilizing the retrograde transport properties of a chimeric envelope for broad distribution.
  • Combining specific tropism and retrograde transport for targeted gene delivery.

Main Results:

  • A novel LV was engineered for efficient gene expression or silencing in astrocytes.
  • The chimeric envelope facilitated retrograde transport, enabling targeting of affected brain circuits.
  • The combined strategy achieved high transduction levels in interconnected brain areas after local administration.

Conclusions:

  • The developed LV and delivery strategy improve gene transfer in the CNS.
  • This approach offers enhanced therapeutic potential for neurodegenerative diseases.
  • Opens new avenues for preclinical gene therapy development in neurological disorders.